Welcome to our cell therapy evaluation platform. Integrating a range of cutting-edge technologies, this platform offers comprehensive solutions for your cell therapy research and product assessment needs.
Platform Features and Applications:
• Car-T: Our technology ensures high cell viability post-transplantation for Car-T cells, delivering more stable and prolonged therapeutic effects.
• Car-T-MHC/KO: Utilizing MHC-deficient mouse models, we can provide a longer observation period while reducing GVHD, ensuring more accurate evaluation outcomes.
• Car-NK: With the high expression of endogenous IL-15, our platform supports the survival and proliferation of Car-NK cells, laying a solid foundation for NK cell therapy.
• Host Versus Graft Reaction (HVG): Leveraging our company's second-generation humanized immune system mouse model, we can evaluate the immunogenicity of various allogeneic transplant cell therapies. This ensures detection of whether the cells will be cleared by the host's immune system, providing critical data support for your cell therapy research.
Our cell therapy evaluation platform combines multiple technologies and models, offering comprehensive support for your research and product development endeavors. Should you have any questions or require further insights, please don't hesitate to contact us.